Fig. 7

Crenigacestat decreases THY1 levels in CD90-positive cells. A Crenigacestat treatment reduces CD90 protein expression in KKU-M213_THY1-scramble sh-RNA but not in KKU-M213_THY1/CD90-shRNA cells. B Crenigacestat treatment significantly reduces CD90 protein expression in HuCCT1_CD90 +  + but not in the HuCCT1_empty vector cells. Magnification: × 20, N.S. No significant difference; **p < 0.01; calculated with Student’s t-test